Skip to main content
Skip to footer
Dicerna Pharmaceuticals
Dicerna
Careers at Dicerna
News
Contact
Search for:
Search Button
Our
Company
Management Team
Board of
Directors
Collaborating
Intellectual Property
Grants & Charitable Donations
Our GalXC™ Technology
Scientific Publications
Pipeline
Nedosiran (formerly DCR-PHXC)
RG6346 (formerly DCR-HBVS)
Belcesiran (formerly DCR-A1AT)
DCR-AUD
Collaborative Programs
Clinical Trials
Patients
A Message To Our Patients
Patient Advocacy Charter
Primary Hyperoxaluria (PH)
Hepatitis B Virus
Alpha-1 Antitrypsin Deficiency-associated Liver Disease
Alcohol Use Disorder (AUD)
Investors & Media
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Investor FAQs
Contact
Application Form
Our
Company
Grants & Charitable Donations
Application Form
Share this page:
Notice: JavaScript is required for this content.
Sign Up for Email Alerts
Our
Company
Management Team
Board of
Directors
Collaborating
Intellectual Property
Grants & Charitable Donations
Our GalXC™ Technology
Scientific Publications
Pipeline
Nedosiran
(DCR-PHXC)
RG6346 (formerly DCR-HBVS)
Belcesiran (formerly DCR-A1AT)
DCR-AUD
Collaborative Programs
Clinical Trials
Patients
A Message To Our Patients
Patient Advocacy Charter
Primary Hyperoxaluria (PH)
Hepatitis B Virus
Alpha-1 Antitrypsin Deficiency-associated Liver Disease
Alcohol Use Disorder (AUD)
Investors & Media
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Investor FAQs
Contact
Careers at Dicerna
News
Contact